Acute chest pain (ACP) is a common clinical presentation that poses a significant diagnostic challenge for clinicians. Its broad differential diagnosis, ranging from benign musculoskeletal conditions to life-threatening emergencies like acute coronary syndrome (ACS), necessitates a comprehensive and systematic approach.
Understanding the patient's history is paramount in the evaluation of ACP. Aspects such as the quality, location, duration, and radiation of pain, coupled with aggravating and relieving factors, can provide valuable clues towards the underlying etiology. The patient's medical history, including risk factors for cardiovascular disease, should also be considered.
Physical examination is a crucial component in the evaluation of ACP. Findings such as a new murmur, unequal pulses, or signs of heart failure may suggest a specific diagnosis. However, a normal examination does not exclude serious causes of chest pain.
Electrocardiogram (ECG) and cardiac biomarkers are the primary diagnostic tools for suspected ACS. Other investigations like chest X-ray, computed tomography (CT) scan, or echocardiography may be required based on the clinical suspicion of other potential causes.
Management of ACP is largely determined by the underlying cause. In suspected ACS, prompt revascularization is the cornerstone of treatment. Other conditions may require medical management, surgical intervention, or simply reassurance and follow-up.
ACP is a complex clinical presentation requiring a thorough and systematic approach. A detailed history, physical examination, and appropriate use of diagnostic tools are key to identifying the underlying cause. Timely and appropriate management can significantly improve patient outcomes. Continued research and education are essential to refine our approach to this common clinical conundrum.
1.
When does a melanoma metastasize? Implications for management
2.
Asandeutertinib Tops Osimertinib for NSCLC With Brain Mets
3.
Mammography with AI support is a secure method for detecting breast cancer.
4.
Compared to previous estimates, a greater number of patients participate in cancer treatment trials.
5.
The biology of cancer as well as potential treatment options are examined by experts.
1.
Case Study: Diagnostic and Therapeutic Challenges in Aplastic Anemia Mimicking Hypoplastic Myelodysplastic Syndrome
2.
HPV and Immunotherapy in Cancer Survivorship: National Cancer Survivors Day Review
3.
Tumor-Associated Stroma Regeneration Models
4.
Colorectal Cancer Incidence Trends: A Growing Concern in 2024 and 2025
5.
Immunotherapy Tolerance in Older Adults With Cancer
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation